Baird raised the firm’s price target on Gilead (GILD) to $95 from $80 and keeps a Neutral rating on the shares. The firm said its was another solid quarter and said the target increase was primarily driven by our expectation that the Sunlenca PrEP opportunity, and to some degree Livdelzi in PBC, has created some new commercial potential.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GILD: